Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Totect

(TOH-tekt)
A drug that contains the active ingredient dexrazoxane and is used to treat severe side effects caused by certain types of anticancer drugs. It is used to reduce heart damage in women who are receiving doxorubicin for breast cancer that has spread to other parts of the body. It is also used to treat the toxic effects of an anticancer drug that leaks from a vein into surrounding tissue and causes tissue damage. Totect is a type of cardioprotective agent, a type of chemoprotective agent, and a type of topoisomerase inhibitor.
More Information
Search NCI's Dictionary of Cancer Terms